EE04312B1 - Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid - Google Patents

Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid

Info

Publication number
EE04312B1
EE04312B1 EEP200000335A EEP200000335A EE04312B1 EE 04312 B1 EE04312 B1 EE 04312B1 EE P200000335 A EEP200000335 A EE P200000335A EE P200000335 A EEP200000335 A EE P200000335A EE 04312 B1 EE04312 B1 EE 04312B1
Authority
EE
Estonia
Prior art keywords
medicaments
dihydrobenzofurans
manufacture
medicaments containing
meaningand
Prior art date
Application number
EEP200000335A
Other languages
English (en)
Estonian (et)
Inventor
Ulrich Wolf-R�diger
Thibaut Ulrich
Hatzelmann Armin
Boss Hildegard
H�fner Dietrich
Beume Rolf
Kley Hans-Peter
Jan Sterk Geert
Timmermann Hendrik
Van Der Mey Margaretha
Johanna Van Der Laan Ivonne
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE200000335A publication Critical patent/EE200000335A/xx
Publication of EE04312B1 publication Critical patent/EE04312B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200000335A 1997-12-15 1998-12-10 Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid EE04312B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97122039 1997-12-15
PCT/EP1998/008054 WO1999031090A1 (en) 1997-12-15 1998-12-10 Dihydrobenzofurans

Publications (2)

Publication Number Publication Date
EE200000335A EE200000335A (et) 2001-10-15
EE04312B1 true EE04312B1 (et) 2004-06-15

Family

ID=8227798

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000335A EE04312B1 (et) 1997-12-15 1998-12-10 Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid

Country Status (17)

Country Link
US (1) US6380196B1 (cs)
EP (1) EP1042319B1 (cs)
JP (1) JP2002508368A (cs)
AT (1) ATE258930T1 (cs)
AU (1) AU753576B2 (cs)
CA (1) CA2314111A1 (cs)
CZ (1) CZ299304B6 (cs)
DE (1) DE69821530T2 (cs)
DK (1) DK1042319T3 (cs)
EE (1) EE04312B1 (cs)
ES (1) ES2216349T3 (cs)
HU (1) HU225114B1 (cs)
IL (1) IL136359A (cs)
PL (1) PL191236B1 (cs)
PT (1) PT1042319E (cs)
SI (1) SI1042319T1 (cs)
WO (1) WO1999031090A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
WO2001019818A1 (en) * 1999-09-14 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Phthalazinone derivatives as pd3/4 inhibitors
US6756371B1 (en) 1999-10-25 2004-06-29 Altana Pharma Ag Phthalazinone derivatives as PDE4 inhibitors
CN1146562C (zh) * 1999-10-25 2004-04-21 奥坦纳医药公司 作为pde4抑制剂的四氢噻喃2,3-二氮杂萘酮类衍生物
PL358057A1 (en) * 2000-06-05 2004-08-09 Altana Pharma Ag Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
BR0207278A (pt) 2001-02-15 2004-02-10 Altana Pharma Ag Derivados de ftalazinona-piperidina como inibidores de pde4
KR20040008162A (ko) 2001-04-25 2004-01-28 알타나 파마 아게 신규한 프탈라지논
CA2445236A1 (en) * 2001-04-25 2002-10-31 Altana Pharma Ag Piperazino-derivatives and their use as pde4 inhibitor
WO2003082264A1 (en) * 2002-03-29 2003-10-09 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for preventing or treating respiratory disease
WO2004018451A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
JP2005538137A (ja) * 2002-08-10 2005-12-15 アルタナ ファルマ アクチエンゲゼルシャフト ピペリジン−n−オキシド誘導体
WO2004018449A1 (en) * 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
JP4555684B2 (ja) * 2002-08-10 2010-10-06 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Pde4阻害剤としての、ピロリジンジオンにより置換されたピペリジン−フタラゾン
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
US20080227790A1 (en) * 2004-02-04 2008-09-18 Altana Pharma Ag Pyridazinone Derivatives and their Use as Pde4 Inhibitors
CA2554797C (en) * 2004-02-04 2012-09-04 Altana Pharma Ag 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
WO2006095666A1 (ja) * 2005-03-07 2006-09-14 Kyorin Pharmaceutical Co., Ltd. ピラゾロピリジン-4-イルピリダジノン誘導体とその付加塩及びそれらを有効成分とするpde阻害剤
WO2007058392A1 (ja) * 2005-11-21 2007-05-24 Japan Tobacco Inc. ヘテロ環化合物およびその医薬用途
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721784A (en) * 1986-12-22 1988-01-26 Ortho Pharmaceutical Corporation 6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones
ES2075202T3 (es) * 1989-04-17 1995-10-01 Byk Gulden Lomberg Chem Fab Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
JP3120857B2 (ja) 1990-02-19 2000-12-25 中外製薬株式会社 新規な縮合複素環化合物とこれを用いた抗喘息剤
EP0553174B1 (de) * 1990-10-16 1998-07-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Arylpyridazinone
US5449676A (en) * 1991-04-26 1995-09-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyridazines
DE59207016D1 (de) * 1991-07-05 1996-10-02 Byk Gulden Lomberg Chem Fab Verwendung substituierter pyridazine gegen dermatosen
MX9205794A (es) * 1991-10-09 1993-04-01 Syntex Inc Compuesto de benzo- y pirido- piridazinona y piridazinotiona
DE4230755A1 (de) * 1992-09-14 1994-03-17 Schering Ag Verwendung von PDE-Inhibitoren bei der Behandlung von Nieren- und Ureter-Erkrankungen
NZ257955A (en) * 1992-12-02 1996-05-28 Pfizer Catechol diethers pharmaceutical compositions
US5476834A (en) * 1993-03-17 1995-12-19 Sumitomo Chemical Company, Limited Dihydrobenzofuran derivatives, their production and use
PT772610E (pt) * 1994-07-22 2001-03-30 Byk Gulden Lomberg Chem Fab Di-hidrobenzofuranos
CA2173493C (en) 1994-08-09 2008-03-25 Nobuhisa Watanabe Fused pyridazine compounds
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
US5821250A (en) * 1996-02-01 1998-10-13 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents

Also Published As

Publication number Publication date
IL136359A0 (en) 2001-06-14
HUP0004561A2 (hu) 2002-03-28
CZ20002218A3 (cs) 2000-11-15
PL191236B1 (pl) 2006-04-28
JP2002508368A (ja) 2002-03-19
HUP0004561A3 (en) 2002-04-29
AU2270199A (en) 1999-07-05
SI1042319T1 (en) 2004-08-31
WO1999031090A1 (en) 1999-06-24
DE69821530T2 (de) 2004-12-23
PT1042319E (pt) 2004-06-30
EE200000335A (et) 2001-10-15
EP1042319A1 (en) 2000-10-11
CA2314111A1 (en) 1999-06-24
PL341239A1 (en) 2001-03-26
ES2216349T3 (es) 2004-10-16
CZ299304B6 (cs) 2008-06-11
EP1042319B1 (en) 2004-02-04
US6380196B1 (en) 2002-04-30
HU225114B1 (en) 2006-06-28
IL136359A (en) 2003-03-12
ATE258930T1 (de) 2004-02-15
AU753576B2 (en) 2002-10-24
DK1042319T3 (da) 2004-06-01
DE69821530D1 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
EE200000335A (et) Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid
EE05105B1 (et) Fenlfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
EE04054B1 (et) Tetrasoolderivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldav ravim
FI970246A7 (fi) Dihydrobentsofuraanit
DE59711733D1 (de) 3-thiocarbamoylpyrazol-derivate als pestiziden
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
DE59909760D1 (de) Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität
NO20022976D0 (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE224358T1 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
DE69529680D1 (de) 2',5'-phosphorthioat/phosphodiester-oligoadenylate und ihre antiviralen verwendungen
ATE286887T1 (de) Antibakterielle mittel
DE59901563D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória
ATE263560T1 (de) Neue verwendung von citreamicinen
PT1075476E (pt) Novos benzimidazoles e benzoxazoles

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081210